Deep Brain Stimulation for Treatment-Refractory Major Depression
Deep Brain Stimulation for Treatment-Refractory Major Depression
This study will investigate the use of deep brain stimulation (DBS) to reduce symptom severity and enhance the quality of life for patients with treatment-refractory major depression.
Despite advances in pharmacotherapy and psychotherapy for major depression, a substantial number of patients fail to improve significantly even after years of conventional and experimental interventions. Bilateral deep brain stimulation (DBS) to the region of the anterior capsule/ventral striatum is an adjustable and reversible procedure that may be a more effective treatment for patients with major depression. This study will determine the effectiveness, safety, and tolerability of DBS in patients with treatment-refractory major depression.
Inclusion Criteria:
Major depression (MD), severe, unipolar type
German mother tongue
Hamilton Depression Rating Scale (HDRS24) score of > 20
Global Assessment of Function (GAF) score of < 45
At least 4 episodes of MD or chronic episode > 2 years
> 5 years after first episode of MD
Failure to respond to *adequate trials (>5 weeks at the maximum recommended or tolerated dose) of primary antidepressants from at least 3 different classes;
Able to give written informed consent
No medical comorbidity
Drug free or on stable drug regimen at least 6 weeks before study entry
Exclusion Criteria: